Avinger, Inc. (AVGR)

NASDAQ: AVGR · IEX Real-Time Price · USD
3.08
+0.01 (0.33%)
At close: Dec 7, 2023, 2:23 PM
3.05
-0.03 (-0.97%)
After-hours: Dec 7, 2023, 5:47 PM EST
0.33%
Market Cap 3.90M
Revenue (ttm) 7.75M
Net Income (ttm) -18.61M
Shares Out 1.28M
EPS (ttm) -31.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,967
Open 3.03
Previous Close 3.07
Day's Range 3.03 - 3.24
52-Week Range 2.78 - 24.30
Beta 1.29
Analysts Strong Buy
Price Target 5.00 (+62.34%)
Earnings Date Oct 26, 2023

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as wel... [Read more]

Sector Healthcare
IPO Date Jan 30, 2015
Employees 71
Stock Exchange NASDAQ
Ticker Symbol AVGR
Full Company Profile

Financial Performance

In 2022, Avinger's revenue was $8.27 million, a decrease of -18.33% compared to the previous year's $10.13 million. Losses were -$27.24 million, 26.2% more than in 2021.

Financial Statements

Analyst Forecast

According to one analyst, the rating for AVGR stock is "Strong Buy" and the 12-month stock price forecast is $5.0.

Price Target
$5.0
(62.34% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Avinger Reports Third Quarter 2023 Results

REDWOOD CITY, CA / ACCESSWIRE / October 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, cathet...

6 weeks ago - Accesswire

Avinger to Announce Third Quarter 2023 Results on October 26

REDWOOD CITY, CA / ACCESSWIRE / October 19, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

7 weeks ago - Accesswire

Avinger Raises $5.3 Million via At-The-Market Facility

Strengthens Balance Sheet in Support of Tigereye ST Launch and Coronary Product Development REDWOOD CITY, CA / ACCESSWIRE / September 27, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical...

2 months ago - Accesswire

Avinger stock rockets off a record low after launch of vascular disease treatment system

Shares of Avinger Inc. skyrocketed 63.5% on heavy volume in morning trading Monday, enough to make them the biggest gainers trading on major U.S. exchanges, after the medical device company announced ...

2 months ago - Market Watch

Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device

REDWOOD CITY, CA / ACCESSWIRE / September 18, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based syst...

2 months ago - Accesswire

Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023

REDWOOD CITY, CA / ACCESSWIRE / August 24, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system ...

3 months ago - Accesswire

Avinger Announces Conversion of 12% of CRG Term Debt into Equity

REDWOOD CITY, CA / ACCESSWIRE / August 4, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter...

4 months ago - Accesswire

Avinger Reports Second Quarter 2023 Results

REDWOOD CITY, CA / ACCESSWIRE / July 27, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-...

4 months ago - Accesswire

Avinger to Announce Second Quarter 2023 Results on July 27

REDWOOD CITY, CA / ACCESSWIRE / July 20, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system fo...

5 months ago - Accesswire

Avinger Announces Presentations by Key Opinion Leaders at LINC 2023

REDWOOD CITY, CA / ACCESSWIRE / June 20, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system fo...

6 months ago - Accesswire

Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

REDWOOD CITY, CA / ACCESSWIRE / June 9, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

6 months ago - Accesswire

Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System

REDWOOD CITY, CA / ACCESSWIRE / June 7, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

6 months ago - Accesswire

Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device

REDWOOD CITY, CA / ACCESSWIRE / June 5, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

6 months ago - Accesswire

Avinger Reports First Quarter 2023 Results

REDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-b...

7 months ago - Accesswire

Avinger to Announce First Quarter 2023 Results on May 10

REDWOOD CITY, CA / ACCESSWIRE / May 2, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

7 months ago - Accesswire

Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium

REDWOOD CITY, CA / ACCESSWIRE / April 28, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f...

7 months ago - Accesswire

Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System

REDWOOD CITY, CA / ACCESSWIRE / April 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f...

8 months ago - Accesswire

Avinger Reports Fourth Quarter 2022 Results

REDWOOD CITY, CA / ACCESSWIRE / March 15, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter...

9 months ago - Accesswire

Avinger to Announce Fourth Quarter 2022 Results on March 15

REDWOOD CITY, CA / ACCESSWIRE / March 2, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system fo...

10 months ago - Accesswire

Avinger Announces 510(k) Filing of Pantheris LV

Pantheris LV Represents the Next-Generation of Onboard Image-Guided Technology for the Treatment of Peripheral Artery Disease REDWOOD CITY, CA / ACCESSWIRE / January 11, 2023 / Avinger, Inc. (NASDAQ:A...

11 months ago - Accesswire

Avinger Reports Third Quarter 2022 Results

REDWOOD CITY, CA / ACCESSWIRE / November 9, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, cathet...

1 year ago - Accesswire

Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices

REDWOOD CITY, CA / ACCESSWIRE / November 4, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, cathet...

1 year ago - Accesswire

Avinger to Announce Third Quarter 2022 Results on November 9

REDWOOD CITY, CA / ACCESSWIRE / November 1, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

1 year ago - Accesswire

Avinger to Present at LD Micro Investor Conference

REDWOOD CITY, CA / ACCESSWIRE / October 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, cathet...

1 year ago - Accesswire

Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022

REDWOOD CITY, CA / ACCESSWIRE / September 1, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, cathe...

1 year ago - Accesswire